Review
Copyright ©The Author(s) 2015.
World J Gastrointest Pathophysiol. Nov 15, 2015; 6(4): 193-202
Published online Nov 15, 2015. doi: 10.4291/wjgp.v6.i4.193
Table 1 Potential treatment alternatives and their drug targets
Drug targetPotential treatment alternatives
NGFTanezumab
TRPV1TRPV1 antagonist
PAR2Trypsin inhibitors
Mast cellKetotifen
Interleukin 1Recombinant interleukin-1 receptor antagonist
Interleukin 6Interleukin-6 antagonist
Central sensitizationKetamine, dextromethrophan, pregabalin, tricyclic antidepressants, and noradrenaline reuptake inhibitors